Peters Jeffrey Stuart 4

4 · MACROGENICS INC · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 17, 2026

MacroGenics (MGNX) SVP Jeffrey Peters Receives RSUs, Exercises Derivative

What Happened

Jeffrey Stuart Peters, Senior Vice President, General Counsel and Secretary of MacroGenics, was granted RSU awards and effected a conversion/exercise of a derivative. On Feb 12, 2026 he was awarded two RSU grants totaling 175,000 restricted stock units (150,000 + 25,000) at $0.00 (convertible one-for-one into common stock). On Feb 15, 2026 the filing shows a conversion/exercise of 13,332 derivative shares; concurrently 5,147 shares were withheld/disposed to cover tax liability at $1.71 per share for a cash value of $8,801.

Key Details

Transactions reported:
- 2026-02-12: Grant/Award (A) — 150,000 RSUs @ $0.00 (acquired)
- 2026-02-12: Grant/Award (A) — 25,000 RSUs @ $0.00 (acquired)
- 2026-02-15: Exercise/Conversion (M) — 13,332 shares (acquired per filing)
- 2026-02-15: Tax withholding (F) — 5,147 shares disposed at $1.71 each = $8,801
- Filing also notes an M-line of 13,332 shares disposed at $0.00 (reflecting the derivative conversion mechanics)
RSUs convert one-for-one into common shares; the A-code entries are awards (no cash outlay reported).
The F-code disposition represents shares withheld to satisfy tax withholding on the conversion/vesting.
Shares owned after the transactions: not specified in the provided excerpt of the filing.
Filing date: Feb 17, 2026 (as reported in the SEC accession).

Context

For retail investors: the awards are grants of restricted stock units (future shares subject to vesting), not open-market purchases. The Feb 15 conversion and the simultaneous withholding of 5,147 shares for taxes is a common administrative step when RSUs vest or derivatives are exercised (similar to a cashless/withhold-for-taxes settlement).
Footnotes in the filing reference prior RSU grants and vesting schedules (e.g., a Feb 15, 2023 grant of 40,000 RSUs and various vesting tranche descriptions). These describe how and when RSUs become payable and do not by themselves indicate intent to buy or sell stock.

Form 4

Period: 2026-02-12

Senior VP, GC, and Secretary

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-15+13,332→ 36,252 total
Tax Payment
Common Stock
2026-02-15$1.71/sh−5,147$8,801→ 31,105 total
Exercise/Conversion
Restricted Stock Unit
[F1]
2026-02-15−13,332→ 0 total
→ Common Stock (13,332 underlying)
Award
Employee Stock Option (right to buy)
[F2]
2026-02-12+150,000→ 150,000 total
Exercise: $1.71Exp: 2036-02-12→ Common Stock (150,000 underlying)
Award
Restricted Stock Unit
[F3]
2026-02-12+25,000→ 25,000 total
→ Common Stock (25,000 underlying)

Footnotes (3)

[F1]On February 15, 2023, the reporting person was granted 40,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
[F2]12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
[F3]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Signature

/s/ Beth A. Smith, Attorney-in-fact|2026-02-17

1 file